Patents by Inventor Yongmei FENG

Yongmei FENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USING NUCLEOSOME INTERACTING PROTEIN DOMAINS TO ENHANCE TARGETED GENOME MODIFICATION
    Publication number: 20210024916
    Abstract: Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.
    Type: Application
    Filed: February 18, 2020
    Publication date: January 28, 2021
    Inventors: Fuqiang Chen, Xiao Ding, Yongmei Feng, Gregory Davis
  • USING NUCLEOSOME INTERACTING PROTEIN DOMAINS TO ENHANCE TARGETED GENOME MODIFICATION
    Publication number: 20200208135
    Abstract: Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.
    Type: Application
    Filed: February 18, 2020
    Publication date: July 2, 2020
    Inventors: Fuqiang Chen, Xiao Ding, Yongmei Feng, Gregory Davis
  • Using nucleosome interacting protein domains to enhance targeted genome modification
    Patent number: 10604752
    Abstract: Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: March 31, 2020
    Assignee: Sigma-Aldrich Co. LLC
    Inventors: Fuqiang Chen, Xiao Ding, Yongmei Feng, Gregory D. Davis
  • Quinolinones as inhibitors of translation initiation complex
    Patent number: 10577349
    Abstract: Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: March 3, 2020
    Assignees: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ze'ev Ronai, Anthony B. Pinkerton, Yongmei Feng, Ivan Topisirovic, Kevin Brown, Christian A. Hassig
  • USING NUCLEOSOME INTERACTING PROTEIN DOMAINS TO ENHANCE TARGETED GENOME MODIFICATION
    Publication number: 20190017042
    Abstract: Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.
    Type: Application
    Filed: July 10, 2018
    Publication date: January 17, 2019
    Inventors: Fuqiang Chen, Xiao Ding, Yongmei Feng, Gregory D. Davis
  • Quinolinones as Inhibitors of Translation Initiation Complex
    Publication number: 20180044324
    Abstract: Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.
    Type: Application
    Filed: March 1, 2016
    Publication date: February 15, 2018
    Inventors: Ze'ev RONAI, Anthony B. PINKERTON, Yongmei FENG, Ivan TOPISIROVIC, Kevin BROWN, Christian A. HASSIG